Search
Arbutus Biopharma Corp
ABUSAdd to Watchlist
4.870USD
+0.140+2.96%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
959.14MMarket Cap
5.87P/E TTM
Arbutus Biopharma Corp Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
14.08M
128.21%
EPS(YoY)
-0.17
53.58%
Analyst Rating
BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total revenue reached 14.08M, with a year-on-year change of 128.21.
What are the current assets of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its current assets were 94.46M, with a year-on-year change of -25.81.
What are the total assets of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total assets of Arbutus Biopharma Corp were 94.62M, with a year-on-year change of -28.16.
What are the total liabilities of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total liabilities of Arbutus Biopharma Corp were 18.04M, with a year-on-year change of -47.46.
What is the total equity of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its total equity of Arbutus Biopharma Corp was 76.58M, with a year-on-year change of -21.35.
What is the net investment of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net investment of Arbutus Biopharma Corp was 15.58M, with a year-on-year change of -32.11.
What is the net financing of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net financing of Arbutus Biopharma Corp was 5.72M, with a year-on-year change of -89.00.
What is the Earnings Per Share (EPS) of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.17, with a year-on-year change of 53.58.
What is the net margin of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its net profit margin was -237.88, with a year-on-year change of 79.00.
What is the debt-to-asset ratio of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its debt-to-asset ratio was 3.64, with a year-on-year change of -0.78.
What is the Return on Equity (ROE) of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its Return on Equity (ROE) was -38.52, with a year-on-year change of 43.98.
What is the Return on Assets (ROA) of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its Return on Assets (ROA) was -29.60, with a year-on-year change of 41.55.
What is the operating profit of Arbutus Biopharma Corp?
According to Arbutus Biopharma Corp's FY2025 earnings report, its operating profit was -27.05M, with a year-on-year change of 61.34.